TuHURA BIOSCIENCES, INC./NV Temporary Equity, Foreign Currency Translation Adjustments
TuHURA BIOSCIENCES, INC./NV (HURA) reported Temporary Equity, Foreign Currency Translation Adjustments of $0 for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-01-18.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments · last filed 2013-01-18
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for the quarter ending 2012-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for the quarter ending 2012-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for the quarter ending 2012-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for the quarter ending 2012-03-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for fiscal 2012 was $0.00.
- TuHURA BIOSCIENCES, INC./NV temporary equity, foreign currency translation adjustments for fiscal 2011 was -$78.00.
| Period end | Temporary Equity, Foreign Currency Translation Adjustments 3 month | Temporary Equity, Foreign Currency Translation Adjustments 6 month | Temporary Equity, Foreign Currency Translation Adjustments 9 month | Temporary Equity, Foreign Currency Translation Adjustments 12 month | Temporary Equity, Foreign Currency Translation Adjustments 27 month | Temporary Equity, Foreign Currency Translation Adjustments 30 month | Temporary Equity, Foreign Currency Translation Adjustments 33 month | Temporary Equity, Foreign Currency Translation Adjustments 36 month | Temporary Equity, Foreign Currency Translation Adjustments 39 month | Temporary Equity, Foreign Currency Translation Adjustments 42 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 10-Q · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | -$87.00 10-Q · filed 2013-01-18 | |||||
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2012-12-20 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-12-20 | |||||
| 2012-06-30 | $0.00 10-K/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 10-K/A · filed 2012-12-20 | -$87.00 10-K/A · filed 2012-12-20 | |||||
| 2012-03-31 | $0.00 10-Q/A · filed 2012-06-05 | $0.00 derived: sum of 2 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-06-05 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | -$87.00 10-Q/A · filed 2012-06-05 | |||||
| 2011-12-31 | $0.00 10-Q · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | -$63.00 derived: sum of 4 quarters · filed 2013-01-18 | -$87.00 10-Q · filed 2012-02-07 | |||||
| 2011-09-30 | $0.00 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | -$63.00 derived: sum of 3 quarters · filed 2012-12-20 | -$78.00 derived: sum of 4 quarters · filed 2012-12-20 | -$87.00 10-Q · filed 2011-11-10 | |||||
| 2011-06-30 | $0.00 10-K/A · filed 2012-12-20 | -$63.00 derived: sum of 2 quarters · filed 2012-12-20 | -$78.00 derived: sum of 3 quarters · filed 2012-12-20 | -$78.00 10-K/A · filed 2012-12-20 | ||||||
| 2011-03-31 | -$63.00 10-Q/A · filed 2012-06-05 | -$78.00 derived: sum of 2 quarters · filed 2012-06-05 | -$78.00 10-Q/A · filed 2012-06-05 | |||||||
| 2010-12-31 | -$15.00 10-Q · filed 2012-02-07 | -$15.00 10-Q · filed 2012-02-07 | ||||||||
| 2010-09-30 | -$1.00 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |